title: Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma: A Comparative Analysis of the Results of Mexico and Venezuela.
authors.affiliation: Ti Salud, Mexico City, Mexico.
authors.forename: B
authors.initials: B
authors.lastname: Meza-Torres
authors.affiliation: Ti Salud, Mexico City, Mexico.
authors.forename: J G
authors.initials: JG
authors.lastname: Gay
authors.affiliation: Takeda Pharmaceuticals, Zurich, Switzerland.
authors.forename: D E
authors.initials: DE
authors.lastname: Jakouloff